The standard for cancer detection has relied on scans and tissue biopsies for decades. They work—but they’re invasive, expensive, and they only show one snapshot in time. Now, scientists are exploring a different idea: what if cancer leaves clues behind in the blood that we can read early and repeatedly?
As tumors grow, they shed living cancer cells, fragments of tumor DNA, and powerful biomarkers into the bloodstream.
These signals travel through the entire body, carrying real-time information about the cancer.
A 2023 study in the Journal of the National Comprehensive Cancer Network found that low vitamin D before paclitaxel chemotherapy may raise the risk of a painful side effect called peripheral neuropathy If you’re starting chemotherapy, ask your doctor about checking your vitamin D levels. Supplementing could be an easy way to help reduce painful chemo side effects, though more research is still needed to confirm.
Giving immunotherapy before chemo seemed to make the immune system more active against the cancer. if these results are confirmed in larger trials, starting immunotherapy before chemo and surgery could become a new standard approach for certain stomach and esophageal cancers. If you or a loved one is facing this diagnosis, it’s worth asking your doctor about clinical trials exploring this strategy.
For years, we’ve been told lung cancer is mainly about smoking and genetic mutations. And while that’s true, it may not be the whole story. A growing body of research suggests something else plays a major role — inflammation. Let’s think about it this way. Mutations might strike the match, but inflammation may be the oxygen that keeps the fire burning. Every day, your body forms abnormal cells. Most of them are removed quietly by your immune system. So why do some grow into cancer? Researchers now believe chronic inflammation creates the kind of environment that allows mutated cells to survive, grow, and spread.
Testicular cancer is the most common cancer diagnosed in adolescent and young adult men, yet it remains one of the most treatable forms of cancer when detected early. Advances in treatment over the past several decades have transformed outcomes, with cure rates now exceeding 95% for many patients. Recent research is also highlighting new approaches that could further improve diagnosis, monitoring, and long-term survivorship.